NONOF News and Press, Novo-Nordisk A/S From 08/10/23

2023-08-10 11:41:04 ET Novo Nordisk A/S (NVO) Q2 2023 Earnings Conference Call August 10, 2023, 07:00 ET Company Participants Daniel Bohsen - CVP & Head, IR Lars Jorgensen - President & CEO Camilla Sylvest - EVP, Commercial Strategy & Corporate Affair...

2023-08-10 07:12:07 ET More on Novo Nordisk Novo Nordisk: Market Leader In A Growing Market Novo Nordisk: High Valuation Reflects Promising Outlook In Obesity Care Novo Nordisk: Denmark's Coca-Cola Novo Nordisk weight loss drug cuts heart disease risk by 20% ...

2023-08-10 03:20:17 ET Novo Nordisk press release ( NVO ): Q2 GAAP EPS of DKK 8.63. Revenue of DKK 54.3B (+31.6% Y/Y) and by 36% at CER compared to the same period in 2022. The increased global sales of 36% at CER were driven by Diabetes and Obesity care sales as GLP-1 dia...

2023-08-08 14:45:47 ET Summary Eli Lilly and Company reported Q2 results exceeding expectations and raised 2023 revenue guidance. Novo Nordisk A/S announced positive results for Phase 3 study of GLP-1 drug Wegovy in reducing cardiovascular events. GLP-1 therapy for obesity pre...

2023-08-08 13:05:05 ET Summary Eli Lilly and Company's Q2 2023 earnings were boosted by strong sales growth of three key products in its pipeline: Verzenio, Jardiance, and Mounjaro. Verzenio, a breast cancer drug, saw significant sales growth due to its approval for multiple indic...

2023-08-08 10:47:02 ET Drugmakers with weight loss candidates in their pipelines are trading higher on Tuesday after the Danish drugmaker Novo Nordisk ( NVO ) said its obesity therapy Wegovy cut major cardiovascular events such as heart attack and stroke by 20% in a large late-stage t...

2023-08-08 10:34:31 ET Summary Viatris Inc. announced its Q2 2023 earnings yesterday. Total net sales were $3.9bn, and free cash flow $447m. While like-for-like product sales grew year-on-year, EBITDA and FCF declined significantly, owing to increased SG&A and R&D spending...

2023-08-06 12:00:54 ET Only a tiny fraction of adults in the U.S. are using prescription weight loss drugs, while many more are looking forward to taking them if the meds are proven to be safe and effective, a new survey by the healthcare policy organization Kaiser Family Foundation shows. ...

2023-08-04 13:06:37 ET ResMed ( NYSE: RMD ) fell 17% on Friday to reach a 52-week low after the respiratory device maker reported lower than expected financials for Q4 fiscal 2023 despite challenges faced by its top competitor, Philips ( PHG ). Days ago, the Dutch me...

2023-07-27 16:39:52 ET Summary Viking Therapeutics, Inc. results from a phase 1 study using an oral version of VK2735 for the treatment of patients with obesity expected Q4 of 2023. Initiation of phase 2 study using intravenous version of VK2735 for the treatment of patients with ...